{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,4]],"date-time":"2026-11-04T20:37:39Z","timestamp":1793824659571,"version":"4.6.1"},"reference-count":133,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2025,7,1]],"date-time":"2025-07-01T00:00:00Z","timestamp":1751328000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,7,1]],"date-time":"2025-07-01T00:00:00Z","timestamp":1751328000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,9,12]],"date-time":"2024-09-12T00:00:00Z","timestamp":1726099200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100005230","name":"Natural Science Foundation of Chongqing Municipality","doi-asserted-by":"publisher","award":["CSTB2023NSCQ-JQX0023"],"award-info":[{"award-number":["CSTB2023NSCQ-JQX0023"]}],"id":[{"id":"10.13039\/501100005230","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100019531","name":"Science Fund for Distinguished Young Scholars of Chongqing Municipality","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100019531","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81830075"],"award-info":[{"award-number":["81830075"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82122044"],"award-info":[{"award-number":["82122044"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["U23A20411"],"award-info":[{"award-number":["U23A20411"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100012166","name":"National Key Research and Development Program of China","doi-asserted-by":"publisher","award":["2018YFA0800802"],"award-info":[{"award-number":["2018YFA0800802"]}],"id":[{"id":"10.13039\/501100012166","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Genes & Diseases"],"published-print":{"date-parts":[[2025,7]]},"DOI":"10.1016\/j.gendis.2024.101436","type":"journal-article","created":{"date-parts":[[2024,9,24]],"date-time":"2024-09-24T12:18:27Z","timestamp":1727180307000},"page":"101436","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":5,"title":["Advances in the mechanism and therapies of achondroplasia"],"prefix":"10.1016","volume":"12","author":[{"given":"Hangang","family":"Chen","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ruobin","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Min","family":"Jin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jing","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lin","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2865-1126","authenticated-orcid":false,"given":"Yangli","family":"Xie","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"10","key":"10.1016\/j.gendis.2024.101436_bib1","doi-asserted-by":"crossref","first-page":"2297","DOI":"10.1002\/ajmg.a.61787","article-title":"Birth prevalence of achondroplasia: a systematic literature review and meta-analysis","volume":"182","author":"Foreman","year":"2020","journal-title":"Am J Med Genetics Pt A"},{"issue":"3","key":"10.1016\/j.gendis.2024.101436_bib2","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1038\/s41574-021-00595-x","article-title":"International Consensus Statement on the diagnosis, multidisciplinary management and lifelong care of individuals with achondroplasia","volume":"18","author":"Savarirayan","year":"2022","journal-title":"Nat Rev Endocrinol"},{"issue":"2","key":"10.1016\/j.gendis.2024.101436_bib3","first-page":"368","article-title":"Achondroplasia is defined by recurrent G380R mutations of FGFR3","volume":"56","author":"Bellus","year":"1995","journal-title":"Am J Hum Genet"},{"issue":"1","key":"10.1016\/j.gendis.2024.101436_bib4","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s13023-018-0972-6","article-title":"Achondroplasia: a comprehensive clinical review","volume":"14","author":"Pauli","year":"2019","journal-title":"Orphanet J Rare Dis"},{"issue":"4","key":"10.1016\/j.gendis.2024.101436_bib5","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1002\/dvdy.24479","article-title":"Achondroplasia: development, pathogenesis, and therapy","volume":"246","author":"Ornitz","year":"2017","journal-title":"Dev Dynam"},{"issue":"2","key":"10.1016\/j.gendis.2024.101436_bib6","doi-asserted-by":"crossref","first-page":"609","DOI":"10.1073\/pnas.2237184100","article-title":"Defective lysosomal targeting of activated fibroblast growth factor receptor 3 in achondroplasia","volume":"101","author":"Cho","year":"2004","journal-title":"Proc Natl Acad Sci USA"},{"issue":"1","key":"10.1016\/j.gendis.2024.101436_bib7","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1016\/j.bone.2003.09.002","article-title":"Overexpression of FGFR3, Stat1, Stat5 and p21Cip1 correlates with phenotypic severity and defective chondrocyte differentiation in FGFR3-related chondrodysplasias","volume":"34","author":"Legeai-Mallet","year":"2004","journal-title":"Bone"},{"issue":"11","key":"10.1016\/j.gendis.2024.101436_bib8","doi-asserted-by":"crossref","first-page":"2914","DOI":"10.1093\/hmg\/ddu004","article-title":"FGFR3 mutation causes abnormal membranous ossification in achondroplasia","volume":"23","author":"Di Rocco","year":"2014","journal-title":"Hum Mol Genet"},{"issue":"5","key":"10.1016\/j.gendis.2024.101436_bib9","doi-asserted-by":"crossref","first-page":"905","DOI":"10.1016\/j.bone.2010.07.020","article-title":"Delayed bone age due to a dual effect of FGFR3 mutation in Achondroplasia","volume":"47","author":"Pannier","year":"2010","journal-title":"Bone"},{"issue":"18","key":"10.1016\/j.gendis.2024.101436_bib10","doi-asserted-by":"crossref","first-page":"E1233","DOI":"10.1097\/BRS.0b013e3182063e89","article-title":"Analysis of sagittal spinopelvic parameters in achondroplasia","volume":"36","author":"Hong","year":"2011","journal-title":"Spine"},{"issue":"1","key":"10.1016\/j.gendis.2024.101436_bib11","doi-asserted-by":"crossref","first-page":"4699","DOI":"10.1038\/s41598-020-61704-w","article-title":"Lumbar spinal stenosis and disc alterations affect the upper lumbar spine in adults with achondroplasia","volume":"10","author":"Huet","year":"2020","journal-title":"Sci Rep"},{"key":"10.1016\/j.gendis.2024.101436_bib12","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1016\/j.bone.2015.04.035","article-title":"Bone development","volume":"80","author":"Berendsen","year":"2015","journal-title":"Bone"},{"issue":"3","key":"10.1016\/j.gendis.2024.101436_bib13","doi-asserted-by":"crossref","first-page":"658","DOI":"10.1016\/j.bbrc.2004.11.068","article-title":"Molecular mechanisms of endochondral bone development","volume":"328","author":"Provot","year":"2005","journal-title":"Biochem Biophys Res Commun"},{"issue":"4","key":"10.1016\/j.gendis.2024.101436_bib14","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1016\/S1534-5807(02)00157-0","article-title":"Reaching a genetic and molecular understanding of skeletal development","volume":"2","author":"Karsenty","year":"2002","journal-title":"Dev Cell"},{"issue":"1","key":"10.1016\/j.gendis.2024.101436_bib15","doi-asserted-by":"crossref","first-page":"a008334","DOI":"10.1101\/cshperspect.a008334","article-title":"Development of the endochondral skeleton","volume":"5","author":"Long","year":"2013","journal-title":"Cold Spring Harbor Perspect Biol"},{"issue":"2","key":"10.1016\/j.gendis.2024.101436_bib16","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1016\/j.devcel.2010.07.010","article-title":"Osteoblast precursors, but not mature osteoblasts, move into developing and fractured bones along with invading blood vessels","volume":"19","author":"Maes","year":"2010","journal-title":"Dev Cell"},{"issue":"4","key":"10.1016\/j.gendis.2024.101436_bib17","doi-asserted-by":"crossref","first-page":"625","DOI":"10.1007\/s00467-009-1368-6","article-title":"Transcriptional networks controlling chondrocyte proliferation and differentiation during endochondral ossification","volume":"25","author":"Wuelling","year":"2010","journal-title":"Pediatr Nephrol"},{"issue":"1","key":"10.1016\/j.gendis.2024.101436_bib18","doi-asserted-by":"crossref","first-page":"5","DOI":"10.2478\/v10042-009-0007-1","article-title":"Morphology and physiology of the epiphyseal growth plate","volume":"47","author":"Burdan","year":"2009","journal-title":"Folia Histochem Cytobiol"},{"issue":"4","key":"10.1016\/j.gendis.2024.101436_bib19","doi-asserted-by":"crossref","first-page":"330","DOI":"10.1002\/bdrc.20057","article-title":"Fate of the hypertrophic chondrocyte: microenvironmental perspectives on apoptosis and survival in the epiphyseal growth plate","volume":"75","author":"Shapiro","year":"2005","journal-title":"Birth Defect Res C"},{"issue":"33","key":"10.1016\/j.gendis.2024.101436_bib20","doi-asserted-by":"crossref","first-page":"12097","DOI":"10.1073\/pnas.1302703111","article-title":"Hypertrophic chondrocytes can become osteoblasts and osteocytes in endochondral bone formation","volume":"111","author":"Yang","year":"2014","journal-title":"Proc Natl Acad Sci USA"},{"issue":"10","key":"10.1016\/j.gendis.2024.101436_bib21","doi-asserted-by":"crossref","first-page":"1266","DOI":"10.1038\/cr.2014.111","article-title":"Osteogenic fate of hypertrophic chondrocytes","volume":"24","author":"Yang","year":"2014","journal-title":"Cell Res"},{"issue":"7730","key":"10.1016\/j.gendis.2024.101436_bib22","doi-asserted-by":"crossref","first-page":"254","DOI":"10.1038\/s41586-018-0662-5","article-title":"Resting zone of the growth plate houses a unique class of skeletal stem cells","volume":"563","author":"Mizuhashi","year":"2018","journal-title":"Nature"},{"issue":"5","key":"10.1016\/j.gendis.2024.101436_bib23","doi-asserted-by":"crossref","first-page":"964","DOI":"10.1002\/jbmr.3658","article-title":"Possible contribution of wnt-responsive chondroprogenitors to the postnatal murine growth plate","volume":"34","author":"Usami","year":"2019","journal-title":"J Bone Miner Res"},{"issue":"4","key":"10.1016\/j.gendis.2024.101436_bib24","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1016\/j.joca.2006.09.010","article-title":"The structural architecture of adult mammalian articular cartilage evolves by a synchronized process of tissue resorption and neoformation during postnatal development [published correction appears in Osteoarthritis Cartilage. 2007;15(9):1099]","volume":"15","author":"Hunziker","year":"2007","journal-title":"Osteoarthritis Cartilage"},{"issue":"4","key":"10.1016\/j.gendis.2024.101436_bib25","doi-asserted-by":"crossref","first-page":"677","DOI":"10.1016\/S0736-0266(00)00040-1","article-title":"Homology of lubricin and superficial zone protein (SZP): products of megakaryocyte stimulating factor (MSF) gene expression by human synovial fibroblasts and articular chondrocytes localized to chromosome 1q25","volume":"19","author":"Jay","year":"2001","journal-title":"J Orthop Res"},{"issue":"1","key":"10.1016\/j.gendis.2024.101436_bib26","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1007\/s11914-014-0247-7","article-title":"Synovial joints: from development to homeostasis","volume":"13","author":"Longobardi","year":"2015","journal-title":"Curr Osteoporos Rep"},{"key":"10.1016\/j.gendis.2024.101436_bib27","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1016\/j.matbio.2014.08.006","article-title":"Genesis and morphogenesis of limb synovial joints and articular cartilage","volume":"39","author":"Decker","year":"2014","journal-title":"Matrix Biol"},{"issue":"12","key":"10.1016\/j.gendis.2024.101436_bib28","doi-asserted-by":"crossref","first-page":"2577","DOI":"10.1016\/j.celrep.2016.05.055","article-title":"Joint development involves a continuous influx of Gdf5-positive cells","volume":"15","author":"Shwartz","year":"2016","journal-title":"Cell Rep"},{"key":"10.1016\/j.gendis.2024.101436_bib29","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1016\/j.semcdb.2021.10.003","article-title":"Somite development and regionalisation of the vertebral axial skeleton","volume":"127","author":"Weldon","year":"2022","journal-title":"Semin Cell Dev Biol"},{"issue":"1","key":"10.1016\/j.gendis.2024.101436_bib30","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.devcel.2010.07.004","article-title":"A skeleton in the closet: neogenin guides bone development","volume":"19","author":"Podkowa","year":"2010","journal-title":"Dev Cell"},{"issue":"3","key":"10.1016\/j.gendis.2024.101436_bib31","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1016\/j.coms.2010.05.001","article-title":"Genetic and transcriptional control of bone formation","volume":"22","author":"Javed","year":"2010","journal-title":"Oral Maxillofac Surg Clin"},{"issue":"4","key":"10.1016\/j.gendis.2024.101436_bib32","doi-asserted-by":"crossref","first-page":"446","DOI":"10.1002\/aja.1002040410","article-title":"Changes in the expression of fibroblast growth factor receptors mark distinct stages of chondrogenesis in vitro and during chick limb skeletal patterning","volume":"204","author":"Szebenyi","year":"1995","journal-title":"Dev Dynam"},{"issue":"2","key":"10.1016\/j.gendis.2024.101436_bib33","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1006\/dbio.1993.1040","article-title":"Unique expression pattern of the FGF receptor 3 gene during mouse organogenesis","volume":"155","author":"Peters","year":"1993","journal-title":"Dev Biol"},{"issue":"4","key":"10.1016\/j.gendis.2024.101436_bib34","doi-asserted-by":"crossref","first-page":"390","DOI":"10.1038\/ng0496-390","article-title":"Skeletal overgrowth and deafness in mice lacking fibroblast growth factor receptor 3","volume":"12","author":"Colvin","year":"1996","journal-title":"Nat Genet"},{"issue":"21","key":"10.1016\/j.gendis.2024.101436_bib35","doi-asserted-by":"crossref","first-page":"13007","DOI":"10.1074\/jbc.273.21.13007","article-title":"Fibroblast growth factor receptor 3 mutations promote apoptosis but do not alter chondrocyte proliferation in thanatophoric dysplasia","volume":"273","author":"Legeai-Mallet","year":"1998","journal-title":"J Biol Chem"},{"issue":"2","key":"10.1016\/j.gendis.2024.101436_bib36","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1016\/j.cytogfr.2005.02.003","article-title":"FGF signaling in the developing endochondral skeleton","volume":"16","author":"Ornitz","year":"2005","journal-title":"Cytokine Growth Factor Rev"},{"issue":"1","key":"10.1016\/j.gendis.2024.101436_bib37","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1016\/S0925-4773(98)00133-6","article-title":"Spatio-temporal expression of FGFR 1, 2 and 3 genes during human embryo-fetal ossification","volume":"77","author":"Delezoide","year":"1998","journal-title":"Mech Dev"},{"issue":"9","key":"10.1016\/j.gendis.2024.101436_bib38","doi-asserted-by":"crossref","first-page":"1845","DOI":"10.1242\/dev.127.9.1845","article-title":"Integration of FGF and TWIST in calvarial bone and suture development","volume":"127","author":"Rice","year":"2000","journal-title":"Development"},{"issue":"11","key":"10.1016\/j.gendis.2024.101436_bib39","doi-asserted-by":"crossref","first-page":"1517","DOI":"10.1172\/JCI6690","article-title":"Gly369Cys mutation in mouse FGFR3 causes achondroplasia by affecting both chondrogenesis and osteogenesis","volume":"104","author":"Chen","year":"1999","journal-title":"J Clin Invest"},{"issue":"8","key":"10.1016\/j.gendis.2024.101436_bib40","doi-asserted-by":"crossref","first-page":"4455","DOI":"10.1073\/pnas.96.8.4455","article-title":"A mouse model for achondroplasia produced by targeting fibroblast growth factor receptor 3","volume":"96","author":"Wang","year":"1999","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"1","key":"10.1016\/j.gendis.2024.101436_bib41","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1093\/hmg\/8.1.35","article-title":"A Lys644Glu substitution in fibroblast growth factor receptor 3 (FGFR3) causes dwarfism in mice by activation of STATs and Ink4 cell cycle inhibitors","volume":"8","author":"Li","year":"1999","journal-title":"Hum Mol Genet"},{"issue":"6622","key":"10.1016\/j.gendis.2024.101436_bib42","doi-asserted-by":"crossref","first-page":"288","DOI":"10.1038\/386288a0","article-title":"Activation of Statl by mutant fibroblast growth-factor receptor in thanatophoric dysplasia type II dwarfism","volume":"386","author":"Su","year":"1997","journal-title":"Nature"},{"issue":"11","key":"10.1016\/j.gendis.2024.101436_bib43","doi-asserted-by":"crossref","first-page":"1361","DOI":"10.1101\/gad.13.11.1361","article-title":"FGF signaling inhibits chondrocyte proliferation and regulates bone development through the STAT-1 pathway","volume":"13","author":"Sahni","year":"1999","journal-title":"Genes Dev"},{"issue":"3","key":"10.1016\/j.gendis.2024.101436_bib44","doi-asserted-by":"crossref","first-page":"290","DOI":"10.1101\/gad.1179104","article-title":"Constitutive activation of MEK1 in chondrocytes causes Stat1-independent achondroplasia-like dwarfism and rescues the Fgfr3-deficient mouse phenotype","volume":"18","author":"Murakami","year":"2004","journal-title":"Genes Dev"},{"issue":"6","key":"10.1016\/j.gendis.2024.101436_bib45","doi-asserted-by":"crossref","first-page":"2900","DOI":"10.1210\/endo.139.6.6032","article-title":"Effects of fibroblast growth factor-2 on longitudinal bone growth","volume":"139","author":"Mancilla","year":"1998","journal-title":"Endocrinology"},{"issue":"1","key":"10.1016\/j.gendis.2024.101436_bib46","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1359\/jbmr.2000.15.1.155","article-title":"Expression of FGFR3 with the G380R achondroplasia mutation inhibits proliferation and maturation of CFK2 chondrocytic cells","volume":"15","author":"Henderson","year":"2000","journal-title":"J Bone Miner Res"},{"issue":"1","key":"10.1016\/j.gendis.2024.101436_bib47","doi-asserted-by":"crossref","first-page":"152","DOI":"10.1016\/j.yexcr.2004.03.011","article-title":"FGF2 inhibits proliferation and alters the cartilage-like phenotype of RCS cells","volume":"297","author":"Krejci","year":"2004","journal-title":"Exp Cell Res"},{"issue":"5","key":"10.1016\/j.gendis.2024.101436_bib48","doi-asserted-by":"crossref","first-page":"623","DOI":"10.1007\/s00776-009-1355-6","article-title":"Increased p21 expression in chondrocytes of achondroplasic children independently from the presence of the G380R FGFR3 mutation","volume":"14","author":"Parafioriti","year":"2009","journal-title":"J Orthop Sci"},{"issue":"31","key":"10.1016\/j.gendis.2024.101436_bib49","doi-asserted-by":"crossref","first-page":"29347","DOI":"10.1074\/jbc.M101859200","article-title":"Fibroblast growth factor inhibits chondrocytic growth through induction of p21 and subsequent inactivation of cyclin E-Cdk2","volume":"276","author":"Aikawa","year":"2001","journal-title":"J Biol Chem"},{"issue":"1","key":"10.1016\/j.gendis.2024.101436_bib50","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1186\/2049-1891-3-39","article-title":"Fibroblast growth factor receptor 3 effects on proliferation and telomerase activity in sheep growth plate chondrocytes","volume":"3","author":"Smith","year":"2012","journal-title":"J Anim Sci Biotechnol"},{"issue":"9","key":"10.1016\/j.gendis.2024.101436_bib51","doi-asserted-by":"crossref","first-page":"4321","DOI":"10.3390\/ijms22094321","article-title":"Signaling pathways in bone development and their related skeletal dysplasia","volume":"22","author":"Guasto","year":"2021","journal-title":"Int J Mol Sci"},{"issue":"24","key":"10.1016\/j.gendis.2024.101436_bib52","doi-asserted-by":"crossref","first-page":"4977","DOI":"10.1242\/dev.125.24.4977","article-title":"Repression of hedgehog signaling and BMP4 expression in growth plate cartilage by fibroblast growth factor receptor 3","volume":"125","author":"Naski","year":"1998","journal-title":"Development"},{"issue":"11","key":"10.1016\/j.gendis.2024.101436_bib53","doi-asserted-by":"crossref","first-page":"1603","DOI":"10.1093\/hmg\/9.11.1603","article-title":"A neonatal lethal mutation in FGFR3 uncouples proliferation and differentiation of growth plate chondrocytes in embryos","volume":"9","author":"Iwata","year":"2000","journal-title":"Hum Mol Genet"},{"issue":"6","key":"10.1016\/j.gendis.2024.101436_bib54","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pgen.1005214","article-title":"FGFR3 deficiency causes multiple chondroma-like lesions by upregulating hedgehog signaling","volume":"11","author":"Zhou","year":"2015","journal-title":"PLoS Genet"},{"issue":"3","key":"10.1016\/j.gendis.2024.101436_bib55","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1093\/jmicro\/dfq002","article-title":"FGFR3 down-regulates PTH\/PTHrP receptor gene expression by mediating JAK\/STAT signaling in chondrocytic cell line","volume":"59","author":"Li","year":"2010","journal-title":"J Electron Microsc"},{"issue":"5","key":"10.1016\/j.gendis.2024.101436_bib56","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1093\/hmg\/10.5.457","article-title":"A Ser365\u2192Cys mutation of fibroblast growth factor receptor 3 in mouse downregulates Ihh\/PTHrP signals and causes severe achondroplasia","volume":"10","author":"Chen","year":"2001","journal-title":"Hum Mol Genet"},{"issue":"6","key":"10.1016\/j.gendis.2024.101436_bib57","doi-asserted-by":"crossref","first-page":"911","DOI":"10.1016\/S0092-8674(00)81069-7","article-title":"Fibroblast growth factor receptor 3 is a negative regulator of bone growth","volume":"84","author":"Deng","year":"1996","journal-title":"Cell"},{"issue":"3","key":"10.1016\/j.gendis.2024.101436_bib58","doi-asserted-by":"crossref","first-page":"439","DOI":"10.1016\/S1534-5807(02)00261-7","article-title":"Interaction of FGF, Ihh\/Pthlh, and BMP signaling integrates chondrocyte proliferation and hypertrophic differentiation","volume":"3","author":"Minina","year":"2002","journal-title":"Dev Cell"},{"issue":"3","key":"10.1016\/j.gendis.2024.101436_bib59","doi-asserted-by":"crossref","first-page":"1113","DOI":"10.1073\/pnas.97.3.1113","article-title":"Up-regulation of the chondrogenic Sox9 gene by fibroblast growth factors is mediated by the mitogen-activated protein kinase pathway","volume":"97","author":"Murakami","year":"2000","journal-title":"Proc Natl Acad Sci USA"},{"issue":"5","key":"10.1016\/j.gendis.2024.101436_bib60","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1016\/S0945-053X(00)00094-9","article-title":"Transcriptional mechanisms of chondrocyte differentiation","volume":"19","author":"de Crombrugghe","year":"2000","journal-title":"Matrix Biol"},{"issue":"21","key":"10.1016\/j.gendis.2024.101436_bib61","doi-asserted-by":"crossref","first-page":"4628","DOI":"10.1093\/hmg\/dds305","article-title":"Disruption of a Sox9-\u03b2-catenin circuit by mutant Fgfr3 in thanatophoric dysplasia type II","volume":"21","author":"Shung","year":"2012","journal-title":"Hum Mol Genet"},{"issue":"6","key":"10.1016\/j.gendis.2024.101436_bib62","doi-asserted-by":"crossref","first-page":"1764","DOI":"10.1093\/hmg\/ddu594","article-title":"Mutant activated FGFR3 impairs endochondral bone growth by preventing SOX9 downregulation in differentiating chondrocytes","volume":"24","author":"Zhou","year":"2015","journal-title":"Hum Mol Genet"},{"issue":"3","key":"10.1016\/j.gendis.2024.101436_bib63","doi-asserted-by":"crossref","first-page":"443","DOI":"10.1016\/j.joca.2014.11.013","article-title":"Sequential exposure to fibroblast growth factors (FGF) 2, 9 and 18 enhances hMSC chondrogenic differentiation","volume":"23","author":"Correa","year":"2015","journal-title":"Osteoarthritis Cartilage"},{"issue":"2","key":"10.1016\/j.gendis.2024.101436_bib64","doi-asserted-by":"crossref","first-page":"300","DOI":"10.1016\/j.ydbio.2007.04.048","article-title":"FGF9 regulates early hypertrophic chondrocyte differentiation and skeletal vascularization in the developing stylopod","volume":"307","author":"Hung","year":"2007","journal-title":"Dev Biol"},{"issue":"6","key":"10.1016\/j.gendis.2024.101436_bib65","doi-asserted-by":"crossref","first-page":"1053","DOI":"10.1083\/jcb.200302075","article-title":"A network of transcriptional and signaling events is activated by FGF to induce chondrocyte growth arrest and differentiation","volume":"161","author":"Dailey","year":"2003","journal-title":"J Cell Biol"},{"issue":"2","key":"10.1016\/j.gendis.2024.101436_bib66","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1016\/j.bone.2006.11.030","article-title":"Sustained phosphorylation of mutated FGFR3 is a crucial feature of genetic dwarfism and induces apoptosis in the ATDC5 chondrogenic cell line via PLC\u03b3-activated STAT1","volume":"41","author":"Harada","year":"2007","journal-title":"Bone"},{"issue":"8","key":"10.1016\/j.gendis.2024.101436_bib67","doi-asserted-by":"crossref","first-page":"1395","DOI":"10.1359\/jbmr.2003.18.8.1395","article-title":"PTHrP rescues ATDC5 cells from apoptosis induced by FGF receptor 3 mutation","volume":"18","author":"Yamanaka","year":"2003","journal-title":"J Bone Miner Res"},{"issue":"1","key":"10.1016\/j.gendis.2024.101436_bib68","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1016\/j.bone.2010.03.021","article-title":"FGFR3 signaling induces a reversible senescence phenotype in chondrocytes similar to oncogene-induced premature senescence","volume":"47","author":"Krejci","year":"2010","journal-title":"Bone"},{"issue":"1","key":"10.1016\/j.gendis.2024.101436_bib69","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1002\/humu.21636","article-title":"Sixteen years and counting: the current understanding of fibroblast growth factor receptor 3 (FGFR3) signaling in skeletal dysplasias","volume":"33","author":"Foldynova-Trantirkova","year":"2012","journal-title":"Hum Mutat"},{"issue":"21","key":"10.1016\/j.gendis.2024.101436_bib70","doi-asserted-by":"crossref","first-page":"5089","DOI":"10.1242\/jcs.02618","article-title":"Interaction of fibroblast growth factor and C-natriuretic peptide signaling in regulation of chondrocyte proliferation and extracellular matrix homeostasis","volume":"118","author":"Krejci","year":"2005","journal-title":"J Cell Sci"},{"issue":"19","key":"10.1016\/j.gendis.2024.101436_bib71","doi-asserted-by":"crossref","first-page":"2645","DOI":"10.1101\/gad.1711308","article-title":"Proteoglycan desulfation determines the efficiency of chondrocyte autophagy and the extent of FGF signaling during endochondral ossification","volume":"22","author":"Settembre","year":"2008","journal-title":"Genes Dev"},{"issue":"7581","key":"10.1016\/j.gendis.2024.101436_bib72","doi-asserted-by":"crossref","first-page":"272","DOI":"10.1038\/nature16063","article-title":"FGF signalling regulates bone growth through autophagy","volume":"528","author":"Cinque","year":"2015","journal-title":"Nature"},{"issue":"11","key":"10.1016\/j.gendis.2024.101436_bib73","doi-asserted-by":"crossref","first-page":"1998","DOI":"10.1080\/15548627.2015.1091551","article-title":"FGFR3\/fibroblast growth factor receptor 3 inhibits autophagy through decreasing the ATG12-ATG5 conjugate, leading to the delay of cartilage development in achondroplasia","volume":"11","author":"Wang","year":"2015","journal-title":"Autophagy"},{"issue":"1","key":"10.1016\/j.gendis.2024.101436_bib74","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1093\/hmg\/ddx374","article-title":"Constitutively-active FGFR3 disrupts primary cilium length and IFT20 trafficking in various chondrocyte models of achondroplasia","volume":"27","author":"Martin","year":"2018","journal-title":"Hum Mol Genet"},{"issue":"6","key":"10.1016\/j.gendis.2024.101436_bib75","doi-asserted-by":"crossref","first-page":"1093","DOI":"10.1093\/hmg\/ddy031","article-title":"Regulation of ciliary function by fibroblast growth factor signaling identifies FGFR3-related disorders achondroplasia and thanatophoric dysplasia as ciliopathies","volume":"27","author":"Kunova Bosakova","year":"2018","journal-title":"Hum Mol Genet"},{"issue":"2","key":"10.1016\/j.gendis.2024.101436_bib76","doi-asserted-by":"crossref","first-page":"117","DOI":"10.3109\/08977194.2012.656761","article-title":"FGF\/FGFR signaling in bone formation: progress and perspectives","volume":"30","author":"Marie","year":"2012","journal-title":"Growth Factors"},{"issue":"2","key":"10.1016\/j.gendis.2024.101436_bib77","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1002\/dvdy.21790","article-title":"Skeletal analysis of the Fgfr3P244R mouse, a genetic model for the Muenke craniosynostosis syndrome","volume":"238","author":"Twigg","year":"2009","journal-title":"Dev Dynam"},{"issue":"7","key":"10.1016\/j.gendis.2024.101436_bib78","doi-asserted-by":"crossref","first-page":"1199","DOI":"10.1093\/hmg\/ddp590","article-title":"Gain-of-function mutation in FGFR3 in mice leads to decreased bone mass by affecting both osteoblastogenesis and osteoclastogenesis","volume":"19","author":"Su","year":"2010","journal-title":"Hum Mol Genet"},{"issue":"4","key":"10.1016\/j.gendis.2024.101436_bib79","article-title":"An Fgfr3-activating mutation in immature murine osteoblasts affects the appendicular and craniofacial skeleton","volume":"14","author":"Biosse","year":"2021","journal-title":"Dis Model Mech"},{"issue":"16","key":"10.1016\/j.gendis.2024.101436_bib80","doi-asserted-by":"crossref","first-page":"7111","DOI":"10.7150\/thno.45286","article-title":"Fgfr3 mutation disrupts chondrogenesis and bone ossification in zebrafish model mimicking CATSHL syndrome partially via enhanced Wnt\/\u03b2-catenin signaling","volume":"10","author":"Sun","year":"2020","journal-title":"Theranostics"},{"issue":"9","key":"10.1016\/j.gendis.2024.101436_bib81","doi-asserted-by":"crossref","first-page":"1782","DOI":"10.1002\/jbmr.4042","article-title":"FGFR3 is a positive regulator of osteoblast expansion and differentiation during zebrafish skull vault development","volume":"35","author":"Dambroise","year":"2020","journal-title":"J Bone Miner Res"},{"issue":"2","key":"10.1016\/j.gendis.2024.101436_bib82","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1093\/hmg\/ddn339","article-title":"FGFR3 promotes synchondrosis closure and fusion of ossification centers through the MAPK pathway","volume":"18","author":"Matsushita","year":"2009","journal-title":"Hum Mol Genet"},{"issue":"11","key":"10.1016\/j.gendis.2024.101436_bib83","doi-asserted-by":"crossref","first-page":"2503","DOI":"10.1093\/hmg\/dds065","article-title":"An activating Fgfr3 mutation affects trabecular bone formation via a paracrine mechanism during growth","volume":"21","author":"Mugniery","year":"2012","journal-title":"Hum Mol Genet"},{"issue":"48","key":"10.1016\/j.gendis.2024.101436_bib84","doi-asserted-by":"crossref","first-page":"24912","DOI":"10.1074\/jbc.M116.730093","article-title":"Chondrocyte FGFR3 regulates bone mass by inhibiting osteogenesis","volume":"291","author":"Wen","year":"2016","journal-title":"J Biol Chem"},{"issue":"3","key":"10.1016\/j.gendis.2024.101436_bib85","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1093\/hmg\/ddh034","article-title":"Defective bone mineralization and osteopenia in young adult FGFR3\u2212\/\u2212 mice","volume":"13","author":"Valverde-Franco","year":"2004","journal-title":"Hum Mol Genet"},{"issue":"1","key":"10.1016\/j.gendis.2024.101436_bib86","doi-asserted-by":"crossref","first-page":"7319","DOI":"10.1038\/s41467-022-34804-6","article-title":"The fate of early perichondrial cells in developing bones","volume":"13","author":"Matsushita","year":"2022","journal-title":"Nat Commun"},{"issue":"1","key":"10.1016\/j.gendis.2024.101436_bib87","doi-asserted-by":"crossref","first-page":"2383","DOI":"10.1038\/s41467-023-38034-2","article-title":"Bone marrow endosteal stem cells dictate active osteogenesis and aggressive tumorigenesis","volume":"14","author":"Matsushita","year":"2023","journal-title":"Nat Commun"},{"issue":"3","key":"10.1016\/j.gendis.2024.101436_bib88","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1038\/ng0395-321","article-title":"Thanatophoric dysplasia (types I and II) caused by distinct mutations in fibroblast growth factor receptor 3","volume":"9","author":"Tavormina","year":"1995","journal-title":"Nat Genet"},{"issue":"7","key":"10.1016\/j.gendis.2024.101436_bib89","doi-asserted-by":"crossref","first-page":"1280","DOI":"10.1093\/hmg\/ddx029","article-title":"A point mutation in Fgf9 impedes joint interzone formation leading to multiple synostoses syndrome","volume":"26","author":"Tang","year":"2017","journal-title":"Hum Mol Genet"},{"issue":"R1","key":"10.1016\/j.gendis.2024.101436_bib90","doi-asserted-by":"crossref","first-page":"R2","DOI":"10.1093\/hmg\/ddv419","article-title":"Advances in treatment of achondroplasia and osteoarthritis","volume":"25","author":"Klag","year":"2016","journal-title":"Hum Mol Genet"},{"issue":"10","key":"10.1016\/j.gendis.2024.101436_bib91","doi-asserted-by":"crossref","first-page":"2432","DOI":"10.1002\/art.39739","article-title":"Fibroblast growth factor receptor 3 inhibits osteoarthritis progression in the knee joints of adult mice","volume":"68","author":"Tang","year":"2016","journal-title":"Arthritis Rheumatol"},{"key":"10.1016\/j.gendis.2024.101436_bib92","article-title":"Conditional deletion of Fgfr3 in chondrocytes leads to osteoarthritis-like defects in temporomandibular joint of adult mice","volume":"6","author":"Zhou","year":"2016","journal-title":"Sci Rep"},{"issue":"1","key":"10.1016\/j.gendis.2024.101436_bib93","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1136\/annrheumdis-2019-215696","article-title":"FGFR3 deficiency enhances CXCL12-dependent chemotaxis of macrophages via upregulating CXCR7 and aggravates joint destruction in mice","volume":"79","author":"Kuang","year":"2020","journal-title":"Ann Rheum Dis"},{"issue":"6","key":"10.1016\/j.gendis.2024.101436_bib94","doi-asserted-by":"crossref","first-page":"952","DOI":"10.1016\/j.joca.2016.12.024","article-title":"mTORC1 activation downregulates FGFR3 and PTH\/PTHrP receptor in articular chondrocytes to initiate osteoarthritis","volume":"25","author":"Zhang","year":"2017","journal-title":"Osteoarthritis Cartilage"},{"issue":"4","key":"10.1016\/j.gendis.2024.101436_bib95","doi-asserted-by":"crossref","first-page":"907","DOI":"10.1007\/s11999-008-0142-6","article-title":"Lumbar nerve root occupancy in the foramen in achondroplasia","volume":"466","author":"Modi","year":"2008","journal-title":"Clin Orthop Relat Res"},{"issue":"5","key":"10.1016\/j.gendis.2024.101436_bib96","doi-asserted-by":"crossref","first-page":"1871","DOI":"10.1172\/JCI83926","article-title":"Tyrosine kinase inhibitor NVP-BGJ398 functionally improves FGFR3-related dwarfism in mouse model","volume":"126","author":"Komla-Ebri","year":"2016","journal-title":"J Clin Invest"},{"issue":"8","key":"10.1016\/j.gendis.2024.101436_bib97","doi-asserted-by":"crossref","first-page":"1774","DOI":"10.1007\/s00586-013-2680-1","article-title":"Comparative immunolocalisation of perlecan, heparan sulphate, fibroblast growth factor-18, and fibroblast growth factor receptor-3 and their prospective roles in chondrogenic and osteogenic development of the human foetal spine","volume":"22","author":"Shu","year":"2013","journal-title":"Eur Spine J"},{"issue":"3","key":"10.1016\/j.gendis.2024.101436_bib98","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1097\/00007632-199502000-00003","article-title":"Basic fibroblast growth factor immunoreactivity in blood vessels and cells of disc herniations","volume":"20","author":"Tolonen","year":"1995","journal-title":"Spine"},{"issue":"1","key":"10.1016\/j.gendis.2024.101436_bib99","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1186\/s13287-022-02903-2","article-title":"Expansion of FGFR3-positive nucleus pulposus cells plays important roles in postnatal nucleus pulposus growth and regeneration","volume":"13","author":"Xu","year":"2022","journal-title":"Stem Cell Res Ther"},{"key":"10.1016\/j.gendis.2024.101436_bib100","doi-asserted-by":"crossref","DOI":"10.1016\/j.yexmp.2020.104590","article-title":"Effect of fibroblast growth factor 2 on degenerative endplate chondrocyte: from anabolism to catabolism","volume":"118","author":"Song","year":"2021","journal-title":"Exp Mol Pathol"},{"issue":"1","key":"10.1016\/j.gendis.2024.101436_bib101","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1016\/j.jor.2015.01.001","article-title":"Achondroplasia and limb lengthening: results in a UK cohort and review of the literature","volume":"12","author":"Donaldson","year":"2015","journal-title":"J Orthop"},{"issue":"3","key":"10.1016\/j.gendis.2024.101436_bib102","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1586\/17434440.2015.1005604","article-title":"PRECICE intramedullary limb lengthening system","volume":"12","author":"Paley","year":"2015","journal-title":"Expet Rev Med Dev"},{"issue":"5","key":"10.1016\/j.gendis.2024.101436_bib103","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1007\/s00774-003-0425-7","article-title":"Efficacy of growth hormone therapy for patients with skeletal dysplasia","volume":"21","author":"Kanazawa","year":"2003","journal-title":"J Bone Miner Metabol"},{"issue":"1","key":"10.1016\/j.gendis.2024.101436_bib104","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1159\/000446958","article-title":"Height outcome of recombinant human growth hormone treatment in achondroplasia children: a meta-analysis","volume":"86","author":"Miccoli","year":"2016","journal-title":"Horm Res Paediatr"},{"issue":"7","key":"10.1016\/j.gendis.2024.101436_bib105","doi-asserted-by":"crossref","first-page":"873","DOI":"10.1007\/s00431-017-2923-y","article-title":"Final adult height in long-term growth hormone-treated achondroplasia patients","volume":"176","author":"Harada","year":"2017","journal-title":"Eur J Pediatr"},{"issue":"203","key":"10.1016\/j.gendis.2024.101436_bib106","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.3006247","article-title":"Postnatal soluble FGFR3 therapy rescues achondroplasia symptoms and restores bone growth in mice","volume":"5","author":"Garcia","year":"2013","journal-title":"Sci Transl Med"},{"issue":"12","key":"10.1016\/j.gendis.2024.101436_bib107","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0244368","article-title":"In vitro and in vivo characterization of Recifercept, a soluble fibroblast growth factor receptor 3, as treatment for achondroplasia","volume":"15","author":"Gon\u00e7alves","year":"2020","journal-title":"PLoS One"},{"issue":"26","key":"10.1016\/j.gendis.2024.101436_bib108","doi-asserted-by":"crossref","first-page":"5443","DOI":"10.1093\/hmg\/dds390","article-title":"A novel FGFR3-binding peptide inhibits FGFR3 signaling and reverses the lethal phenotype of mice mimicking human thanatophoric dysplasia","volume":"21","author":"Jin","year":"2012","journal-title":"Hum Mol Genet"},{"issue":"7_suppl","key":"10.1016\/j.gendis.2024.101436_bib109","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1200\/JCO.2019.37.7_suppl.409","article-title":"Fierce-21: phase II study of vofatmab (B-701), a selective inhibitor of FGFR3, as salvage therapy in metastatic urothelial carcinoma (mUC)","volume":"37","author":"Necchi","year":"2019","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.gendis.2024.101436_bib110","doi-asserted-by":"crossref","first-page":"819","DOI":"10.1016\/j.omtn.2019.07.018","article-title":"Anti-angiogenic and anti-scarring dual action of an anti-fibroblast growth factor 2 aptamer in animal models of retinal disease","volume":"17","author":"Matsuda","year":"2019","journal-title":"Mol Ther Nucleic Acids"},{"issue":"592","key":"10.1016\/j.gendis.2024.101436_bib111","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.aba4226","article-title":"An RNA aptamer restores defective bone growth in FGFR3-related skeletal dysplasia in mice","volume":"13","author":"Kimura","year":"2021","journal-title":"Sci Transl Med"},{"issue":"4","key":"10.1016\/j.gendis.2024.101436_bib112","doi-asserted-by":"crossref","first-page":"841","DOI":"10.1093\/hmg\/ddr514","article-title":"A novel tyrosine kinase inhibitor restores chondrocyte differentiation and promotes bone growth in a gain-of-function Fgfr3 mouse model","volume":"21","author":"Jonquoy","year":"2012","journal-title":"Hum Mol Genet"},{"issue":"1","key":"10.1016\/j.gendis.2024.101436_bib113","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1093\/hmg\/ddv441","article-title":"Multikinase activity of fibroblast growth factor receptor (FGFR) inhibitors SU5402, PD173074, AZD1480, AZD4547 and BGJ398 compromises the use of small chemicals targeting FGFR catalytic activity for therapy of short-stature syndromes","volume":"25","author":"Gudernova","year":"2016","journal-title":"Hum Mol Genet"},{"key":"10.1016\/j.gendis.2024.101436_bib114","doi-asserted-by":"crossref","DOI":"10.1177\/1759720X221084848","article-title":"Infigratinib in children with achondroplasia: the PROPEL and PROPEL 2 studies","volume":"14","author":"Savarirayan","year":"2022","journal-title":"Ther Adv Musculoskelet Dis"},{"issue":"1","key":"10.1016\/j.gendis.2024.101436_bib115","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-020-77345-y","article-title":"Evaluation of FGFR inhibitor ASP5878 as a drug candidate for achondroplasia","volume":"10","author":"Ozaki","year":"2020","journal-title":"Sci Rep"},{"issue":"1","key":"10.1016\/j.gendis.2024.101436_bib116","doi-asserted-by":"crossref","first-page":"485","DOI":"10.1186\/s13287-021-02555-8","article-title":"Targeted gene correction and functional recovery in achondroplasia patient-derived iPSCs","volume":"12","author":"Zou","year":"2021","journal-title":"Stem Cell Res Ther"},{"issue":"12","key":"10.1016\/j.gendis.2024.101436_bib117","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0081569","article-title":"Meclozine facilitates proliferation and differentiation of chondrocytes by attenuating abnormally activated FGFR3 signaling in achondroplasia","volume":"8","author":"Matsushita","year":"2013","journal-title":"PLoS One"},{"issue":"2","key":"10.1016\/j.gendis.2024.101436_bib118","doi-asserted-by":"crossref","first-page":"548","DOI":"10.1210\/en.2014-1914","article-title":"Meclozine promotes longitudinal skeletal growth in transgenic mice with achondroplasia carrying a gain-of-function mutation in the FGFR3 gene","volume":"156","author":"Matsushita","year":"2015","journal-title":"Endocrinology"},{"issue":"4","key":"10.1016\/j.gendis.2024.101436_bib119","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0229639","article-title":"Pharmacokinetics and safety after once and twice a day doses of meclizine hydrochloride administered to children with achondroplasia","volume":"15","author":"Kitoh","year":"2020","journal-title":"PLoS One"},{"issue":"7","key":"10.1016\/j.gendis.2024.101436_bib120","doi-asserted-by":"crossref","first-page":"4016","DOI":"10.1073\/pnas.071389098","article-title":"Dwarfism and early death in mice lacking C-type natriuretic peptide","volume":"98","author":"Chusho","year":"2001","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"1","key":"10.1016\/j.gendis.2024.101436_bib121","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1038\/nm971","article-title":"Overexpression of CNP in chondrocytes rescues achondroplasia through a MAPK-dependent pathway","volume":"10","author":"Yasoda","year":"2004","journal-title":"Nat Med"},{"issue":"2","key":"10.1016\/j.gendis.2024.101436_bib122","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0212680","article-title":"ASB20123: a novel C-type natriuretic peptide derivative for treatment of growth failure and dwarfism","volume":"14","author":"Morozumi","year":"2019","journal-title":"PLoS One"},{"issue":"12","key":"10.1016\/j.gendis.2024.101436_bib123","doi-asserted-by":"crossref","first-page":"2443","DOI":"10.1038\/s41436-021-01287-7","article-title":"Safe and persistent growth-promoting effects of vosoritide in children with achondroplasia: 2-year results from an open-label, phase 3 extension study","volume":"23","author":"Savarirayan","year":"2021","journal-title":"Genet Med"},{"key":"10.1016\/j.gendis.2024.101436_bib124","doi-asserted-by":"crossref","DOI":"10.1016\/j.eclinm.2023.102258","article-title":"Once-weekly TransCon CNP (navepegritide) in children with achondroplasia (ACcomplisH): a phase 2, multicentre, randomised, double-blind, placebo-controlled, dose-escalation trial","volume":"65","author":"Savarirayan","year":"2023","journal-title":"EClinicalMedicine"},{"issue":"1","key":"10.1016\/j.gendis.2024.101436_bib125","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1038\/s41413-021-00177-7","article-title":"Theobroma cacao improves bone growth by modulating defective ciliogenesis in a mouse model of achondroplasia","volume":"10","author":"Martin","year":"2022","journal-title":"Bone Res"},{"issue":"5275","key":"10.1016\/j.gendis.2024.101436_bib126","doi-asserted-by":"crossref","first-page":"613","DOI":"10.1126\/science.273.5275.613","article-title":"Regulation of rate of cartilage differentiation by Indian hedgehog and PTH-related protein","volume":"273","author":"Vortkamp","year":"1996","journal-title":"Science"},{"issue":"7519","key":"10.1016\/j.gendis.2024.101436_bib127","doi-asserted-by":"crossref","first-page":"507","DOI":"10.1038\/nature13775","article-title":"Statin treatment rescues FGFR3 skeletal dysplasia phenotypes","volume":"513","author":"Yamashita","year":"2014","journal-title":"Nature"},{"issue":"9","key":"10.1016\/j.gendis.2024.101436_bib128","doi-asserted-by":"crossref","first-page":"1522","DOI":"10.1016\/j.joca.2017.05.014","article-title":"Statins do not inhibit the FGFR signaling in chondrocytes","volume":"25","author":"Fafilek","year":"2017","journal-title":"Osteoarthritis Cartilage"},{"issue":"17","key":"10.1016\/j.gendis.2024.101436_bib129","doi-asserted-by":"crossref","first-page":"1863","DOI":"10.1101\/gad.264994.115","article-title":"Fgfr1 regulates development through the combinatorial use of signaling proteins","volume":"29","author":"Brewer","year":"2015","journal-title":"Genes Dev"},{"issue":"1","key":"10.1016\/j.gendis.2024.101436_bib130","doi-asserted-by":"crossref","first-page":"T11","DOI":"10.1530\/JME-14-0012","article-title":"Recent research on the growth plate: advances in fibroblast growth factor signaling in growth plate development and disorders","volume":"53","author":"Xie","year":"2014","journal-title":"J Mol Endocrinol"},{"issue":"3","key":"10.1016\/j.gendis.2024.101436_bib131","doi-asserted-by":"crossref","first-page":"550","DOI":"10.1016\/j.ajhg.2012.02.005","article-title":"Bent bone dysplasia-FGFR2 type, a distinct skeletal disorder, has deficient canonical FGF signaling","volume":"90","author":"Merrill","year":"2012","journal-title":"Am J Hum Genet"},{"issue":"4","key":"10.1016\/j.gendis.2024.101436_bib132","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pbio.1002427","article-title":"Excessive osteocytic Fgf23 secretion contributes to pyrophosphate accumulation and mineralization defect in Hyp mice","volume":"14","author":"Murali","year":"2016","journal-title":"PLoS Biol"},{"issue":"1","key":"10.1016\/j.gendis.2024.101436_bib133","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1038\/s42255-020-00321-3","article-title":"Metabolic regulation of skeletal cell fate and function in physiology and disease","volume":"3","author":"van Gastel","year":"2021","journal-title":"Nat Metab"}],"container-title":["Genes & Diseases"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2352304224002332?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2352304224002332?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,5,5]],"date-time":"2025-05-05T07:33:31Z","timestamp":1746430411000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2352304224002332"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,7]]},"references-count":133,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2025,7]]}},"alternative-id":["S2352304224002332"],"URL":"https:\/\/doi.org\/10.1016\/j.gendis.2024.101436","relation":{},"ISSN":["2352-3042"],"issn-type":[{"value":"2352-3042","type":"print"}],"subject":[],"published":{"date-parts":[[2025,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Advances in the mechanism and therapies of achondroplasia","name":"articletitle","label":"Article Title"},{"value":"Genes & Diseases","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.gendis.2024.101436","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 The Authors. Publishing services by Elsevier B.V. on behalf of KeAi Communications Co., Ltd\u00e9","name":"copyright","label":"Copyright"}],"article-number":"101436"}}